you are here:

Lyka Labs Ltd.

BSE: 500259 | NSE: LYKALABS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE933A01014 | SECTOR: Pharmaceuticals

BSE Live

Dec 08, 16:00
180.55 -9.50 (-5.00%)
Volume
AVERAGE VOLUME
5-Day
376,109
10-Day
342,705
30-Day
429,367
177,775
  • Prev. Close

    190.05

  • Open Price

    182.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    180.55 (7979)

NSE Live

Dec 08, 15:59
179.85 -9.45 (-4.99%)
Volume
AVERAGE VOLUME
5-Day
1,232,080
10-Day
901,919
30-Day
651,172
1,156,184
  • Prev. Close

    189.30

  • Open Price

    184.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    179.85 (80841)

Financials

2020 2019 2018 2017 2016
Cash Flow of Lyka Labs (in Rs. Cr.) Mar 21 Mar 20 Mar 19 Mar 18 Mar 17  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 0.00 -55.15 -7.10 -11.22 -0.56  
Net CashFlow From Operating Activities 0.00 -11.45 18.31 6.84 20.17  
Net Cash Used In Investing Activities 0.00 0.13 -2.94 -3.35 -5.25  
Net Cash Used From Financing Activities 0.00 19.61 -15.76 -4.48 -15.20  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 0.00 8.28 -0.38 -0.99 -0.28  
Cash And Cash Equivalents Begin of Year 0.00 0.12 0.47 1.46 1.73  
Cash And Cash Equivalents End Of Year 0.00 8.40 0.09 0.47 1.46  
Source : Dion Global Solutions Limited